companydata.dkcompanydata.dk

ICEPHARMA A/S: Financial statements 2021

CVR: 36393459

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,436,032 and a net result of DKK -5,423,874 compared with DKK -5,660,020 the year before. Equity in the 2021 report amounted to DKK 689,794. The solvency ratio was 23.7%. The company had 5 employees in the financial year.

Gross Profit
DKK -2,436,032
Profit/Loss
DKK -5,423,874
Equity
DKK 689,794
Total Assets
DKK 2,916,085
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--2.4 mio.-5.4 mio.690 t.5
2020--2.2 mio.-5.7 mio.7 t.5
2019--3.9 mio.-7.7 mio.581 t.5
2018--3.6 mio.-7.2 mio.829 t.5
2017--722 t.-4.8 mio.-579 t.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ICEPHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

ICEPHARMA A/S: The 2020 annual report is outJul 20, 2021

ICEPHARMA A/S has published its annual report for 2020. Gross profit came to DKK -2,207,233, and the net result was DKK -5,660,020.

About ICEPHARMA A/S

ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.

Source: annual report 2025, Danish Business Authority